Personalized Medicine (PM) Market Predict Long term Growth at USD 5208.68 Billion With 12.01% of CAGR By 2022 - Along With Quest Diagnostics, 3G Biotech, Laboratory Corporation of America, Agendia NV, Abbott, AsuragenInc, CardioDx Inc., Becton Dickinson &

The report “Personalized Medicine (PM) Market By Product (PM Diagnostics, PM Therapeutics, Personalized Medical Care and Personalized Nutrition & Wellness) – Global Forecast to 2022”, issued by Crystal Market Research, the market has come across substantial development in the recent years and is projected to grow significantly over the forecast period.

Inquire for sample copy at: https://www.crystalmarketresearch.com/report-sample/HC11358

Personalized Medicine (PM) Market by Product - Global Industry Analysis and Forecast to 2022: Industry Overview
In 2012, the global personalized medicine market was evaluated around USD 806.97 billion and is expected to reach approximately USD 5208.68 billion by 2022 while registering itself at a compound annual growth rate (CAGR) of 12.01% over the forecast period. Major driving factors of the global market are increasing development of whole genome, companion diagnostics, next-generation sequencing technology, and rising retail clinics. Rising healthcare spending levels stimulating the demand for an efficient cancer diagnostic procedure, rising incidence of cancer and growing utilization of amalgamation biomarkers for diagnostics are some factors projected to boost the growth of the global market. Rising implementation of next-generation sequencing by medical practitioners and clinicians for genetic mapping of patients worldwide and increasing support for the personalized drug by regulatory and reimbursement landscape are also expected driving factors for global demand over 2022. Global market growth is also projected to augment via the new drugs introduction that is linked and companion diagnostics, and increasing usage of accurate and extremely sensitive genetic diagnostic method for disease testing as well as risk assessment. The expected rise in advanced DNA diagnostic use along with the decline in implementation price for whole genome sequencing is anticipated to significantly increased rates.

Global Personalized Medicine (PM) Market: Competitive Analysis
The increasing investment in research and development by the players is triggering competition in the global Personalized Medicine (PM) market.

Market players ruling personalized medicine market are occupied in the progression of these testing methodologies to improve public application rates of genetic therapeutic, personalized tailor-made therapy prescriptions and companion diagnostic tests. Major market players are Quest Diagnostics, 3G Biotech, Laboratory Corporation of America, Agendia NV, Abbott, AsuragenInc, CardioDx Inc., Becton Dickinson & Co., Foundation Medicine Inc., Siemens Healthcare Diagnostics Inc., Qiagen Inc., Amgen Inc., GE Healthcare, Bristol-Myers Squibb, Pfizer Inc., 23andMe, Sanofi, Illumina Inc., Astra Zeneca PLC, Roche Holding AG, Vertex Pharmaceuticals Inc., American Association for Cancer Research and Merck & Co. Inc.

The strategic mergers and acquisitions among the players of the global Personalized Medicine (PM) market are leading to the expansion of this market.

For more information about this report visit: https://www.crystalmarketresearch.com/report/personalized-medicine-pm-market

The global personalized medicinemarket is segmented as follows –
By Product:
PM Diagnostics
Genetic Testing
Direct-to-consumer Diagnostics
Esoteric Lab Services
Esoteric Lab Tests

PM Therapeutics:
Pharmaceutical
Genomic Medicine
Medical Devices

Personalized Medical Care:
Telemedicine
Healthcare Information Technology
Diseases Management

Personalized Nutrition & Wellness:
Retail Nutrition
Complementary Medicine
Alternative Medicine

By Region: North America: (U.S, Canada & Mexico), Europe: (Germany, France, UK, Italy, Spain & Rest of Europe), Asia-Pacific: (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific) and Rest of the World: (Brazil, South Africa, Saudi Arabia, Turkey, United Arab Emirates & Others)

Pre Order Enquiry at: https://www.crystalmarketresearch.com/send-an-enquiry/HC11358

Global Personalized Medicine (PM) Market: Regional Analysis
In 2014, North American regional personalized medicine market ruled global demand, due to supportive NIH policies and government funding, rising adoption of clinical practitioners, central consolidation of healthcare IT and EHR systems with hospital operations, and incorporation into clinical trials. Technological advancements of next-generation sequencing ensuing in cost decline of genomic sequencing is too an elevated impact providing factor projected to bestow towards the growth of the market. Though, the Asia-Pacific regional personalized medicine industry is anticipated witness major gains during the forecasted years due to the existence of a considerably large base of unfulfilled industry demand, rising technological progression of the regional medical framework and rising awareness regarding genetic diagnostics, therapeutics, and genomic sequencing.

Key Topics Covered of Global Personalized Medicine (PM) Market:
Chapter 1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research

Chapter 2. Executive Summary
2.1. Key Highlights

Chapter 3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Increasing number of associated diagnostics
3.2.1.2. Rising healthcare spending generating development of effective PM diagnostic & therapeutic
3.2.1.3. Growing prevalence of cancer
3.2.2. Restraints
3.2.2.1. Lack of Technologies
3.2.2.2. Absence of appropriate intellectual property regulations for personalized medical technologies
3.2.3. Opportunities
3.2.3.1. Technological Advancement in Development of Personalized Medicines

Chapter 4. Personalized Medicine (PM) Market, By Product

Chapter 5. Personalized Medicine (PM) Market, By Region

Chapter 6. Company Profiles

…Read Full Table of Contents

Reasons to Buy the Report:
This report focuses on various levels of analysis—industry trends, market ranking of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the rapid microbiology testing market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

(Early customers will receive 10% customization in this report.)

Avail Quality Discount at: https://www.crystalmarketresearch.com/check-discount/HC11358

About Crystal Market Research:
Crystal Market Research (CMR) is a main industry insight arrangement that gives all statistical surveying reports from top distributers, a U.S. based market research and business Intelligence Company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contacts Us:
Judy | 304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
E-mail: sales@crystalmarketresearch.com | Tel: +1-888-213-4282
Web: www.crystalmarketresearch.com

This release was published on openPR.